U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Long Life Unlimited - 533282 - 02/17/2022
  1. Warning Letters

CLOSEOUT LETTER

Long Life Unlimited MARCS-CMS 533282 —

Product:
Dietary Supplements
Recipient:
Recipient Name
Barbara A. Long
Long Life Unlimited

328 E. Kirby St.
Lima, OH 45804
United States

Issuing Office:
Cincinnati District Office

United States

Dear Ms. Long:

The Food and Drug Administration has completed evaluation of your corrective actions in response to our Warning Letter 533282 issued on January 31, 2018. Based on our evaluation of your website: www.longlifeunlimited.com on January 31, 2022, it appears that you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

/S/
Stephen J. Rabe
Compliance Officer

Back to Top